Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.

Zhu D, Judge PK, Francis ST, Che Z, Rayner JJ, Buchanan C, Mayne KJ, Stevens W, Bley T, Bhandary N, Byrne C, Cejka V, Chapman D, Cox EF, Dasgupta T, Malijan GB, Nicholas R, Phelan P, Smith E, Tunnicliffe EM, Wooding N, Nangaku M, Cherney DZI, Selby NM, Taal M, Steubl D, Aoqui C, Wanner C, Emberson JR, Landray MJ, Baigent C, Staplin N, Herrington WG, Haynes R, EMPA-KIDNEY Collaborative Group

Open source

DOI: 10.1053/j.ajkd.2025.09.022
Published: 2026 Apr
Container: American journal of kidney diseases : the official journal of the National Kidney Foundation
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1053/j.ajkd.2025.09.022,
  title = {Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.},
  author = {Zhu D and Judge PK and Francis ST and Che Z and Rayner JJ and Buchanan C and Mayne KJ and Stevens W and Bley T and Bhandary N and Byrne C and Cejka V and Chapman D and Cox EF and Dasgupta T and Malijan GB and Nicholas R and Phelan P and Smith E and Tunnicliffe EM and Wooding N and Nangaku M and Cherney DZI and Selby NM and Taal M and Steubl D and Aoqui C and Wanner C and Emberson JR and Landray MJ and Baigent C and Staplin N and Herrington WG and Haynes R and EMPA-KIDNEY Collaborative Group},
  year = {2026},
  journal = {American journal of kidney diseases : the official journal of the National Kidney Foundation},
  doi = {10.1053/j.ajkd.2025.09.022},
  url = {https://doi.org/10.1053/j.ajkd.2025.09.022}
}

RIS

TY  - JOUR
TI  - Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
AU  - Zhu D
AU  - Judge PK
AU  - Francis ST
AU  - Che Z
AU  - Rayner JJ
AU  - Buchanan C
AU  - Mayne KJ
AU  - Stevens W
AU  - Bley T
AU  - Bhandary N
AU  - Byrne C
AU  - Cejka V
AU  - Chapman D
AU  - Cox EF
AU  - Dasgupta T
AU  - Malijan GB
AU  - Nicholas R
AU  - Phelan P
AU  - Smith E
AU  - Tunnicliffe EM
AU  - Wooding N
AU  - Nangaku M
AU  - Cherney DZI
AU  - Selby NM
AU  - Taal M
AU  - Steubl D
AU  - Aoqui C
AU  - Wanner C
AU  - Emberson JR
AU  - Landray MJ
AU  - Baigent C
AU  - Staplin N
AU  - Herrington WG
AU  - Haynes R
AU  - EMPA-KIDNEY Collaborative Group
PY  - 2026
JO  - American journal of kidney diseases : the official journal of the National Kidney Foundation
DO  - 10.1053/j.ajkd.2025.09.022
UR  - https://doi.org/10.1053/j.ajkd.2025.09.022
ER  -

APA

D, Z., PK, J., ST, F., Z, C., JJ, R., C, B., KJ, M., W, S., T, B., N, B., C, B., V, C., D, C., EF, C., T, D., GB, M., R, N., P, P., E, S., EM, T., N, W., M, N., DZI, C., NM, S., M, T., D, S., C, A., C, W., JR, E., MJ, L., C, B., N, S., WG, H., R, H., & Group, E. C. (2026). Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.. American journal of kidney diseases : the official journal of the National Kidney Foundation. https://doi.org/10.1053/j.ajkd.2025.09.022

Source records

pubmed · retrieved 2026-09-26T13:30:58.294Z